Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

SEHK:2315 Stock Report

Market Cap: HK$2.3b

Biocytogen Pharmaceuticals (Beijing) Future Growth

Future criteria checks 2/6

Biocytogen Pharmaceuticals (Beijing) is forecast to grow revenue at 22.4% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth42.8%
Revenue growth rate22.4%
Future return on equityn/a
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

Recent updates

Is Biocytogen Pharmaceuticals (Beijing) (HKG:2315) A Risky Investment?

May 08
Is Biocytogen Pharmaceuticals (Beijing) (HKG:2315) A Risky Investment?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s (HKG:2315) Price Is Right But Growth Is Lacking

Apr 03
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s (HKG:2315) Price Is Right But Growth Is Lacking

Earnings and Revenue Growth Forecasts

SEHK:2315 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,410N/AN/AN/A1
12/31/20251,216N/AN/AN/A1
12/31/2024947N/AN/AN/A1
6/30/2024801-244-88-29N/A
3/31/2024759-313-146-53N/A
12/31/2023717-383-203-77N/A
9/30/2023674-451-304-143N/A
6/30/2023632-519-404-210N/A
3/31/2023583-561-474-256N/A
12/31/2022534-602-544-303N/A
9/30/2022493-585-538-312N/A
6/30/2022453-569-532-320N/A
3/31/2022404-557-548-343N/A
12/31/2021355-546-564-366N/A
12/31/2020254-217-522-225N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 2315's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 2315's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 2315's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 2315's revenue (22.4% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 2315's revenue (22.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 2315's Return on Equity is forecast to be high in 3 years time


Discover growth companies